| AbbVie AG - Botox 50 Allergan-Einheiten, Pulver zur Herstellung einer Injektionslösung |
| 52433 | | 02 | | Botox 50 Allergan-Einheiten | | Pulver zur Herstellung einer Injektionslösung | | M03AX01 | | Botulinum Toxin | | 24.05.2007 | | |
|
| Composition |
| Praeparatio cryodesiccata: toxinum botulinicum A 50 U., albuminum humanum, natrii chloridum corresp. natrium 0.18 mg, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Dry substance | | | | | | | | Active Agent | Dose |
|---|
| Toxinum Botulinicum A | 50 U |
| | BAG: Active Agent | Dose |
|---|
| Toxinum Botulinicum A | 50 U |
| | | | Inactive agents |
|---|
| Human Albumin | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 2 | 201.70 | 235.80 | A | SL | No |
|
